BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 12637762)

  • 1. Cyclooxygenase-2 expression in canine mammary tumors.
    Doré M; Lanthier I; Sirois J
    Vet Pathol; 2003 Mar; 40(2):207-12. PubMed ID: 12637762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Cox-1 and Cox-2 in canine mammary tumours.
    Queiroga FL; Alves A; Pires I; Lopes C
    J Comp Pathol; 2007; 136(2-3):177-85. PubMed ID: 17416236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular proliferative and telomerase activity in canine mammary gland tumors.
    Funakoshi Y; Nakayama H; Uetsuka K; Nishimura R; Sasaki N; Doi K
    Vet Pathol; 2000 Mar; 37(2):177-83. PubMed ID: 10714647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclooxygenase-2 expression in spontaneous intestinal neoplasia of domestic dogs.
    McEntee MF; Cates JM; Neilsen N
    Vet Pathol; 2002 Jul; 39(4):428-36. PubMed ID: 12126145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclooxygenase-2 expression is associated with histologic tumor type in canine mammary carcinoma.
    Heller DA; Clifford CA; Goldschmidt MH; Holt DE; Shofer FS; Smith A; Sorenmo KU
    Vet Pathol; 2005 Nov; 42(6):776-80. PubMed ID: 16301573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of matrix metalloproteinases in canine mammary tumours: analysis by immunohistochemistry and zymography.
    Hirayama K; Yokota H; Onai R; Kobayashi T; Kumata T; Kihara K; Okamoto M; Sako T; Nakade T; Izumisawa Y; Taniyama H
    J Comp Pathol; 2002 Nov; 127(4):249-56. PubMed ID: 12443732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COX-2 expression in canine normal and neoplastic mammary gland.
    Dias Pereira P; Lopes CC; Matos AJ; Santos M; Gärtner F; Medeiros R; Lopes C
    J Comp Pathol; 2009 May; 140(4):247-53. PubMed ID: 19203768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of bone morphogenetic protein-6 (BMP-6) in myoepithelial cells in canine mammary gland tumors.
    Tateyama S; Uchida K; Hidaka T; Hirao M; Yamaguchi R
    Vet Pathol; 2001 Nov; 38(6):703-9. PubMed ID: 11732805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cox-2 expression in canine mammary carcinomas: correlation with angiogenesis and overall survival.
    Lavalle GE; Bertagnolli AC; Tavares WL; Cassali GD
    Vet Pathol; 2009 Nov; 46(6):1275-80. PubMed ID: 19605908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical reactivity of basal and luminal epithelium-specific cytokeratin antibodies within normal and neoplastic canine mammary glands.
    Griffey SM; Madewell BR; Dairkee SH; Hunt JE; Naydan DK; Higgins RJ
    Vet Pathol; 1993 Mar; 30(2):155-61. PubMed ID: 7682368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An immunohistochemical study of cyclooxygenase-2 expression in various feline neoplasms.
    Beam SL; Rassnick KM; Moore AS; McDonough SP
    Vet Pathol; 2003 Sep; 40(5):496-500. PubMed ID: 12949405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Derlin-1 and stanniocalcin-1 are differentially regulated in metastasizing canine mammary adenocarcinomas.
    Klopfleisch R; Gruber AD
    J Comp Pathol; 2009; 141(2-3):113-20. PubMed ID: 19515379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COX-2, mPGES-1 and EP2 receptor immunohistochemical expression in canine and feline malignant mammary tumours.
    Millanta F; Asproni P; Canale A; Citi S; Poli A
    Vet Comp Oncol; 2016 Sep; 14(3):270-80. PubMed ID: 24824420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progesterone receptor isoform analysis by quantitative real-time polymerase chain reaction in formalin-fixed, paraffin-embedded canine mammary dysplasias and tumors.
    Guil-Luna S; Stenvang J; Brünner N; Sánchez-Céspedes R; Millán Y; Gómez-Laguna J; de las Mulas JM
    Vet Pathol; 2014 Sep; 51(5):895-902. PubMed ID: 24249219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclooxygenase-2 expression in human gastric tubular adenomas and carcinomas; correlation with intratumoral microvessel density and apoptotic index.
    Honjo S; Kase S; Osaki M; Ardyanto TD; Kaibara N; Ito H
    Anticancer Res; 2004; 24(3a):1439-44. PubMed ID: 15274307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomere length and telomerase activity in canine mammary gland tumors.
    Yazawa M; Okuda M; Setoguchi A; Iwabuchi S; Nishimura R; Sasaki N; Masuda K; Ohno K; Tsujimoto H
    Am J Vet Res; 2001 Oct; 62(10):1539-43. PubMed ID: 11592316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of cyclo-oxygenase-2 in naturally occurring squamous cell carcinomas in dogs.
    Pestili de Almeida EM; Piché C; Sirois J; Doré M
    J Histochem Cytochem; 2001 Jul; 49(7):867-75. PubMed ID: 11410611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of cyclooxygenase-2 in canine renal cell carcinoma.
    Khan KN; Stanfield KM; Trajkovic D; Knapp DW
    Vet Pathol; 2001 Jan; 38(1):116-9. PubMed ID: 11199159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of cyclooxygenase-2 in canine epithelial nasal tumors.
    Kleiter M; Malarkey DE; Ruslander DE; Thrall DE
    Vet Radiol Ultrasound; 2004; 45(3):255-60. PubMed ID: 15200266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of cyclooxygenase-1 and 2 in naturally-occurring canine cancer.
    Mohammed SI; Khan KN; Sellers RS; Hayek MG; DeNicola DB; Wu L; Bonney PL; Knapp DW
    Prostaglandins Leukot Essent Fatty Acids; 2004 May; 70(5):479-83. PubMed ID: 15062852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.